Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Receivables: 2013-2025

Historic Change in Receivables for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to -$11.4 million.

  • Phibro Animal Health's Change in Receivables fell 23.44% to -$11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.0 million, marking a year-over-year increase of 333.03%. This contributed to the annual value of $55.2 million for FY2025, which is 536.18% up from last year.
  • According to the latest figures from Q3 2025, Phibro Animal Health's Change in Receivables is -$11.4 million, which was down 143.79% from $26.0 million recorded in Q2 2025.
  • In the past 5 years, Phibro Animal Health's Change in Receivables ranged from a high of $35.0 million in Q4 2024 and a low of -$22.3 million during Q3 2022.
  • Over the past 3 years, Phibro Animal Health's median Change in Receivables value was $3.5 million (recorded in 2025), while the average stood at $5.6 million.
  • As far as peak fluctuations go, Phibro Animal Health's Change in Receivables plummeted by 411.02% in 2022, and later skyrocketed by 7,819.86% in 2024.
  • Over the past 5 years, Phibro Animal Health's Change in Receivables (Quarterly) stood at $2.9 million in 2021, then soared by 154.85% to $7.5 million in 2022, then slumped by 120.44% to -$1.5 million in 2023, then soared by 2,379.41% to $35.0 million in 2024, then decreased by 23.44% to -$11.4 million in 2025.
  • Its Change in Receivables was -$11.4 million in Q3 2025, compared to $26.0 million in Q2 2025 and $3.5 million in Q1 2025.